No. 197a-Fetal Health Surveillance: Antepartum Consensus Guideline

Journal of Obstetrics and Gynaecology Canada

Volumn 40, Issue 4, 2018, Pages e251-e271

  Liston, Robert ^a   Sawchuck, Diane ^a   Young, David ^b  

^a Vancouver Clinic   (United States)

^b NONE   (United States)

Author keywords

antepartum; biophysical profile; contraction stress test; electronic fetal monitoring; fetal movement; Fetal surveillance; intermittent auscultation; intrapartum; non stress test; umbilical Doppler; uterine artery Doppler

Indexed keywords

GLUCOSE;

AMNION FLUID; ANEMIA; ARTICLE; CANADA; CONSENSUS DEVELOPMENT; DISEASE SURVEILLANCE; DOPPLER FLOWMETRY; FETAL BIOPHYSICAL PROFILE; FETUS DEATH; FETUS ECHOGRAPHY; FETUS MOVEMENT; HUMAN; INTRAUTERINE GROWTH RETARDATION; MANUAL FETAL MANIPULATION; NONHUMAN; OXYTOCIN TEST; PERINATAL ASPHYXIA; PERINATAL MORBIDITY; PERINATAL MORTALITY; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; RISK FACTOR; FEMALE; FETUS MONITORING; PERINATAL CARE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

FEMALE; FETAL MONITORING; FETAL MOVEMENT; HUMANS; PERINATAL CARE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ULTRASONOGRAPHY, PRENATAL;

EID: 85045745165     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jogc.2018.02.007     Document Type: Article

References (125)

1. Barrett, J.F., Jarvis, G.J., Macdonald, H.N., et al. Inconsistencies in clinical decisions in obstetrics. Lancet 336 (1990), 549–551.
2. Williams, K.P., Farquharson, D.F., Bebbington, M., et al. Screening for fetal well-being in a high-risk pregnant population comparing the nonstress test with umbilical artery Doppler velocimetry: a randomized controlled clinical trial. Am J Obstet Gynecol 188 (2003), 1366–1371.
3. Canadian perinatal health report 2003, Ottawa: Health Canada. Cat no. H49–142/2003E; Available at http://www.phac-aspc.gc.ca/publicat/cphr-rspc03/pdf/cphr-rspc03_e.pdf, 2003. (Accessed 1 November 2006)
4. Wadhera, S., Strachan, J., Selected mortality statistics, Canada, 1921–1990. Health Rep 5 (1993), 233–238.
5. Alfirevic, Z., Neilson, J.P., Biophysical profile for fetal assessment in high risk pregnancies [Cochrane review]. Cochrane database of systematic reviews, 1996, John Wiley & Sons, Ltd, Chichester (UK, 10.1002/14651858.CD000038 Issue 1.
6. Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Intrapartum fetal surveillance: clinical guidelines. 2nd ed. Melbourne: The College; Available at http://www.ranzcog.edu.au/publications/pdfs/ClinicalGuidelines-IFSSecEd.pdf, 2006. (Accessed 25 July 2007)
7. The use of electronic fetal monitoring: the use and interpretation of cardiotogography in intrapartum fetal surveillance. [Evidence-based clinical guideline no 8]. London: Royal College of Obstetricians and Gynaecologists, 2001.
8. James, D.K., Steer, P.J., Weiner, C.P., et al. High risk pregnancy: management options. 3rd ed., 2006, Elsevier Saunders, Philadelphia.
9. Phelan, J.P., Platt, L.D., Yeh, S.Y., et al. Continuing role of the nonstress test in the management of postdates pregnancy. Obstet Gynecol 64 (1984), 624–628.
10. Browne, J.C., Postmaturity. Am J Obstet Gynecol 85 (1963), 573–582.
11. Torres, P.J., Gratacos, E., Alonso, P.L., Umbilical artery Doppler ultrasound predicts low birth weight and fetal death in hypertensive pregnancies. Acta Obstet Gynecol Scand 74 (1995), 352–355.
12. von Kries, R., Kimmerle, R., Schmidt, J.E., et al. Pregnancy outcomes in mothers with pregestational diabetes: a population-based study in North Rhine (Germany) from 1988 to 1993. Eur J Pediatr 156 (1997), 963–967.
13. Girz, B.A., Divon, M.Y., Merkatz, I.R., Sudden fetal death in women with well-controlled, intensively monitored gestational diabetes. J Perinatol 12 (1992), 229–233.
14. Vintzileos, A.M., Antepartum surveillance in preterm rupture of membranes. J Perinat Med 24 (1996), 319–326.
15. Sholl, J.S., Abruptio placentae: clinical management in nonacute cases. Am J Obstet Gynecol 156 (1987), 40–51.
16. Whittle, W., Chaddha, V., Wyatt, P., et al. Ultrasound detection of placental insufficiency in women with “unexplained” abnormal maternal serum screening results. Clin Genet 69 (2006), 97–104.
17. Schiff, M.A., Holt, V.L., Pregnancy outcomes following hospitalization for motor vehicle crashes in Washington State from 1989 to 2001. Am J Epidemiol 161 (2005), 503–510.
18. Bianco, A.T., Smilen, S.W., Davis, Y., et al. Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol 91 (1998), 97–102.
19. Raatikainen, K., Heiskanen, N., Heinonen, S., Transition from overweight to obesity worsens pregnancy outcome in a BMI-dependent manner. Obesity (Silver Spring) 14 (2006), 165–171.
20. Sadovsky, E., Polishuk, W.Z., Fetal movements in utero: nature, assessment, prognostic value, timing of delivery. Obstet Gynecol 50 (1977), 49–55.
21. Bocking, A.D., Assessment of fetal heart rate and fetal movements in detecting oxygen deprivation in-utero. Eur J Obstet Gynecol Reprod Biol 110:Suppl 1 (2003), S108–S112.
22. Soothill, P.W., Ajayi, R.A., Campbell, S., et al. Prediction of morbidity in small and normally grown fetuses by fetal heart rate variability, biophysical profile score and umbilical artery Doppler studies. Br J Obstet Gynaecol 100 (1993), 742–745.
23. Hannah, M.E., Hannah, W.J., Hellmann, J., et al. Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group. N Engl J Med 326 (1992), 1587–1592.
24. Rouse, D.J., Owen, J., Goldenberg, R.L., et al. Determinants of the optimal time in gestation to initiate antenatal fetal testing: a decision-analytic approach. Am J Obstet Gynecol 173 (1995), 1357–1363.
25. Miller, D.A., Rabello, Y.A., Paul, R.H., The modified biophysical profile: antepartum testing in the 1990s. Am J Obstet Gynecol 174 (1996), 812–817.
26. Froen, J.F., A kick from within—fetal movement counting and the cancelled progress in antenatal care. J Perinat Med 32 (2004), 13–24.
27. Grant, A., Elbourne, D., Valentin, L., et al. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet 2 (1989), 345–349.
28. Baskett, T.F., Liston, R.M., Fetal movement monitoring: clinical application. Clin Perinatol 16 (1989), 613–625.
29. Velazquez, M.D., Rayburn, W.F., Antenatal evaluation of the fetus using fetal movement monitoring. Clin Obstet Gynecol 45 (2002), 993–1004.
30. Connors, G., Natale, R., Nasello-Paterson, C., Maternally perceived fetal activity from twenty-four weeks' gestation to term in normal and at risk pregnancies. Am J Obstet Gynecol 158 (1988), 294–299.
31. Sadovsky, E., Yaffe, H., Daily fetal movement recording and fetal prognosis. Obstet Gynecol 41 (1973), 845–850.
32. Thacker, S.B., Berkelman, R.L., Assessing the diagnostic accuracy and efficacy of selected antepartum fetal surveillance techniques. Obstet Gynecol Surv 41 (1986), 121–141.
33. Rayburn, W.F., Antepartum fetal assessment. Monitoring fetal activity. Clin Perinatol 9 (1982), 231–252.
34. Roberts, A.B., Little, D., Cooper, D., et al. Normal patterns of fetal activity in the third trimester. Br J Obstet Gynaecol 86 (1979), 4–9.
35. Patrick, J., Campbell, K., Carmichael, L., et al. Patterns of gross fetal body movements over 24-hour observation intervals during the last 10 weeks of pregnancy. Am J Obstet Gynecol 142 (1982), 363–371.
36. Hertz, R.H., Timor-Tritsch, I., Dierker, L.J. Jr, et al. Continuous ultrasound and fetal movement. Am J Obstet Gynecol 135 (1979), 152–154.
37. Hatoum, N., Clapp, J.F. III, Newman, M.R., et al. Effects of maternal exercise on fetal activity in late gestation. J Matern Fetal Med 6 (1997), 134–139.
38. Miller, F.C., Skiba, H., Klapholz, H., The effect of maternal blood sugar levels on fetal activity. Obstet Gynecol 52 (1978), 662–665.
39. Birkenfeld, A., Laufer, N., Sadovsky, E., Diurnal variation of fetal activity. Obstet Gynecol 55 (1980), 417–419.
40. Ritchie, J.W., Fetal breathing and generalized fetal movements in normal antenatal patients. Br J Obstet Gynaecol 86 (1979), 612–614.
41. Mirghani, H.M., Weerasinghe, D.S., Ezimokhai, M., et al. The effect of maternal fasting on the fetal biophysical profile. Int J Gynaecol Obstet 81 (2003), 17–21.
42. Goodman, J.D., Visser, F.G., Dawes, G.S., Effects of maternal cigarette smoking on fetal trunk movements, fetal breathing movements and the fetal heart rate. Br J Obstet Gynaecol 91 (1984), 657–661.
43. Jansson, L.M., Dipietro, J., Elko, A., Fetal response to maternal methadone administration. Am J Obstet Gynecol 193:3 Pt 1 (2005), 611–617.
44. Mulder, E.J., Koenen, S.V., Blom, I., et al. The effects of antenatal betamethasone administration on fetal heart rate and behaviour depend on gestational age. Early Hum Dev 76 (2004), 65–77.
45. Pearson, J.F., Weaver, J.B., Fetal activity and fetal wellbeing: an evaluation. Br Med J 1 (1976), 1305–1307.
46. Moore, T.R., Piacquadio, K., A prospective evaluation of fetal movement screening to reduce the incidence of antepartum fetal death. Am J Obstet Gynecol 160:5 Pt 1 (1989), 1075–1080.
47. Sadovsky, E., Weinstein, D., Even, Y., Antepartum fetal evaluation by assessment of fetal heart rate and fetal movements. Int J Gynaecol Obstet 19 (1981), 21–26.
48. Neldam, S., Fetal movements as an indicator of fetal well-being. Dan Med Bull 30 (1983), 274–278.
49. Smith, C.V., Davis, S.A., Rayburn, W.F., Patients' acceptance of monitoring fetal movement. A randomized comparison of charting techniques. J Reprod Med 37 (1992), 144–146.
50. Valentin, L., Lofgren, O., Marsal, K., et al. Subjective recording of fetal movements. I. Limits and acceptability in normal pregnancies. Acta Obstet Gynecol Scand 63 (1984), 223–228.
51. Patrick, J., Fetherston, W., Vick, H., et al. Human fetal breathing movements and gross fetal body movements at weeks 34 to 35 of gestation. Am J Obstet Gynecol 130 (1978), 693–699.
52. Sadovsky, E., Rabinowitz, R., Yaffe, H., Decreased fetal movements and fetal malformations. J Fetal Med, 1, 1981, 62.
53. Rayburn, W.F., McKean, H.E., Maternal perception of fetal movement and perinatal outcome. Obstet Gynecol 56 (1980), 161–164.
54. Rayburn, W.F., Barr, M., Activity patterns in malformed fetuses. Am J Obstet Gynecol 142 (1982), 1045–1048.
55. Harrington, K., Thompson, O., Jordan, L., et al. Obstetric outcome in women who present with a reduction in fetal movements in the third trimester of pregnancy. J Perinat Med 26 (1998), 77–82.
56. Pattison, N., McCowan, L., Cardiotocography for antepartum fetal assessment [Cochrane review]. Cochrane Database of Systematic Reviews, 1999, John Wiley & Sons, Ltd, Chichester (UK), 10.1002/14651858.CD001068 Issue.
57. Barrett, J.M., Salyer, S.L., Boehm, F.H., The nonstress test: an evaluation of 1000 patients. Am J Obstet Gynecol 141 (1981), 153–157.
58. Miller, J.M., Horger, E.O., Antepartum heart rate testing in diabetic pregnancy. J Reprod Med 30 (1985), 515–518.
59. Cito, G., Luisi, S., Mezzesimi, A., et al. Maternal position during non-stress test and fetal heart rate patterns. Acta Obstet Gynecol Scand 84 (2005), 335–338.
60. Freeman, R., Garite, T.J., Nageotte, M.P., Fetal heart rate monitoring. 3rd ed., 2003, Lippincott Williams & Wilkins, Philadelphia.
61. Electronic fetal heart rate monitoring: research guidelines for interpretation. National Institute of Child Health and Human Development Research Planning Workshop. Am J Obstet Gynecol 177 (1997), 1385–1390.
62. Johnson, T.R., Paine, L.L., Strobino, D.M., et al. Population differences affect the interpretation of fetal nonstress test results. Am J Obstet Gynecol 179:3–pt 1 (1998), 779–783.
63. Pratt, D., Diamond, F., Yen, H., et al. Fetal stress and nonstress tests: an analysis and comparison of their ability to identify fetal outcome. Obstet Gynecol 54 (1979), 419–423.
64. Brown, R., Patrick, J., The nonstress test: how long is enough?. Am J Obstet Gynecol 141 (1981), 646–651.
65. Leveno, K.J., Williams, M.L., DePalma, R.T., et al. Perinatal outcome in the absence of antepartum fetal heart rate acceleration. Obstet Gynecol 61 (1983), 347–355.
66. Tan, K.H., Sabapathy, A., Maternal glucose administration for facilitating tests of fetal well-being [Cochrane review]. Cochrane database of systematic reviews, 2001, John Wiley & Sons, Ltd, Chichester (UK, 10.1002/14651858.CD003397 Issue 4.
67. Tan, K.H., Sabapathy, A., Fetal manipulation for facilitating tests of fetal well-being [Cochrane review]. Cochrane database of systematic reviews, 2001, John Wiley & Sons, Ltd, Chichester (UK, 10.1002/14651858.CD003396 Issue 4.
68. Ray, M., Freeman, R., Pine, S., Hesselgesser, R., Clinical experience with the oxytocin challenge test. Am J Obstet Gynecol 114 (1972), 1–9.
69. Lagrew, D.C., The contraction stress test. Clin Obstet Gynecol 38 (1995), 11–25.
70. Creasy, R., Reznik, R., Iams, J., Maternal fetal medicine principles and practice. 5th ed., 2003, W.B. Saunders, Philadelphia.
71. Boehm, F.H., Gabbe, S.G., Putting it all together. Clin Obstet Gynecol 45 (2002), 1063–1068.
72. Huddleston, J.F., Continued utility of the contraction stress test?. Clin Obstet Gynecol 45 (2002), 1005–1014.
73. Copel, J.A., Otis, C.S., Stewart, E., et al. Contraction stress testing with nipple stimulation. J Reprod Med 30 (1985), 465–471.
74. Lipitz, S., Barkai, G., Rabinovici, J., et al. Breast stimulation test and oxytocin challenge test in fetal surveillance: a prospective randomized study. Am J Obstet Gynecol 157 (1987), 1178–1181.
75. MacMillan, J.B., Hale, R.W., Contraction stress testing with mammary self-stimulation. J Reprod Med 29 (1984), 219–221.
76. Freeman, R.K., Anderson, G., Dorchester, W., A prospective multi-institutional study of antepartum fetal heart rate monitoring. I. Risk of perinatal mortality and morbidity according to antepartum fetal heart rate test results. Am J Obstet Gynecol 143 (1982), 771–777.
77. Miller, D.A., Antepartum testing. Clin Obstet Gynecol 41 (1998), 647–653.
78. Braly, P., Freeman, R.K., The significance of fetal heart rate reactivity with a positive oxytocin challenge test. Obstet Gynecol 50 (1977), 689–693.
79. Freeman, R.K., Anderson, G., Dorchester, W., A prospective multi-institutional study of antepartum fetal heart rate monitoring. II. Contraction stress test versus nonstress test for primary surveillance. Am J Obstet Gynecol 143 (1982), 778–781.
80. Manning, F.A., Dynamic ultrasound-based fetal assessment: the fetal biophysical profile score. Clin Obstet Gynecol 38 (1995), 26–44.
81. Cohn, H.E., Sacks, E.J., Heymann, M.A., et al. Cardiovascular responses to hypoxemia and acidemia in fetal lambs. Am J Obstet Gynecol 120 (1974), 817–824.
82. Chamberlain, P.F., Manning, F.A., Morrison, I., et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol 150 (1984), 245–249.
83. Phelan, J.P., Ahn, M.O., Smith, C.V., et al. Amniotic fluid index measurements during pregnancy. J Reprod Med 32 (1987), 601–604.
84. Moore, T.R., Cayle, J.E., The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol 162 (1990), 1168–1173.
85. Moore, T.R., Assessment of amniotic fluid volume in at-risk pregnancies. Clin Obstet Gynecol 38 (1995), 78–90.
86. Magann, E.F., Doherty, D.A., Field, K., et al. Biophysical profile with amniotic fluid volume assessments. Obstet Gynecol 104 (2004), 5–10.
87. Moore, T.R., Sonographic screening for oligohydramnios: does it decrease or increase morbidity?. Obstet Gynecol 104 (2004), 3–4.
88. Chauhan, S.P., Doherty, D.D., Magann, E.F., et al. Amniotic fluid index vs single deepest pocket technique during modified biophysical profile: a randomized clinical trial. Am J Obstet Gynecol 191 (2004), 661–667.
89. Alfirevic, Z., Luckas, M., Walkinshaw, S.A., et al. A randomised comparison between amniotic fluid index and maximum pool depth in the monitoring of post-term pregnancy. Br J Obstet Gynaecol 104 (1997), 207–211.
90. Morris, J.M., Thompson, K., Smithey, J., et al. The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study. BJOG 110 (2003), 989–994.
91. Vintzileos, A.M., Fleming, A.D., Scorza, W.E., et al. Relationship between fetal biophysical activities and umbilical cord blood gas values. Am J Obstet Gynecol 165 (1991), 707–713.
92. Manning, F.A., Snijders, R., Harman, C.R., et al. Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol 169 (1993), 755–763.
93. Dayal, A.K., Manning, F.A., Berck, D.J., et al. Fetal death after normal biophysical profile score: an eighteen-year experience. Am J Obstet Gynecol 181:5 Pt 1 (1999), 1231–1236.
94. Manning, F.A., Fetal biophysical profile: a critical appraisal. Clin Obstet Gynecol 45 (2002), 975–985.
95. Manning, F.A., Bondaji, N., Harman, C.R., et al. Fetal assessment based on fetal biophysical profile scoring. VIII. The incidence of cerebral palsy in tested and untested perinates. Am J Obstet Gynecol 178 (1998), 696–706.
96. Magann, E.F., Isler, C.M., Chauhan, S.P., et al. Amniotic fluid volume estimation and the biophysical profile: a confusion of criteria. Obstet Gynecol 96 (2000), 640–642.
97. Nageotte, M.P., Towers, C.V., Asrat, T., Freeman, R.K., Perinatal outcome with the modified biophysical profile. Am J Obstet Gynecol 170 (1994), 1672–1676.
98. Zimmermann, P., Eirio, V., Koskinen, J., et al. Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for pre-eclampsia and/or intrauterine growth retardation: comparison and correlation between different Doppler parameters. Ultrasound Obstet Gynecol 9 (1997), 330–338.
99. Harrington, K., Fayyad, A., Thakur, V., et al. The value of uterine artery Doppler in the prediction of uteroplacental complications in multiparous women. Ultrasound Obstet Gynecol 23 (2004), 50–55.
100. Newnham, J.P., Patterson, L.L., James, I.R., et al. An evaluation of the efficacy of Doppler flow velocity waveform analysis as a screening test in pregnancy. Am J Obstet Gynecol 162 (1990), 403–410.
101. Harrington, K., Cooper, D., Lees, C., et al. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 7 (1996), 182–188.
102. Gagnon, R., Van den Hof, M., The use of fetal Doppler in obstetrics. SOGC Clinical Practice Guideline No. 130, July 2003. J Obstet Gynaecol Can 25 (2003), 601–607.
103. Adamson, S.L., Arterial pressure, vascular input impedance, and resistance as determinants of pulsatile blood flow in the umbilical artery. Eur J Obstet Gynecol Reprod Biol 84 (1999), 119–125.
104. Kingdom, J.C., Burrell, S.J., Kaufmann, P., Pathology and clinical implications of abnormal umbilical artery Doppler waveforms. Ultrasound Obstet Gynecol 9 (1997), 271–286.
105. Rochelson, B., Schulman, H., Farmakides, G., et al. The significance of absent end-diastolic velocity in umbilical artery velocity waveforms. Am J Obstet Gynecol 156 (1987), 1213–1218.
106. McParland, P., Steel, S., Pearce, J.M., The clinical implications of absent or reversed end-diastolic frequencies in umbilical artery flow velocity wave- forms. Eur J Obstet Gynecol Reprod Biol 37 (1990), 15–23.
107. Schreuder, A.M., McDonnell, M., Gaffney, G., et al. Outcome at school age following antenatal detection of absent or reversed end diastolic flow velocity in the umbilical artery. Arch Dis Child Fetal Neonatal Ed 86 (2002), F108–F114.
108. Neilson, J.P., Alfirevic, Z., Doppler ultrasound for fetal assessment in high risk pregnancies [Cochrane review]. Cochrane database of systematic reviews, 1996, John Wiley & Sons, Ltd, Chichester (UK), 10.1002/14651858.CD000073 Issue 4.
109. Yoon, B.H., Syn, H.C., Kim, S.W., The efficacy of Doppler umbilical artery velocimetry in identifying fetal acidosis. A comparison with fetal biophysical profile. J Ultrasound Med 11 (1992), 1–6.
110. Harman, C.R., Baschat, A.A., Comprehensive assessment of fetal well-being: which Doppler tests should be performed?. Curr Opin Obstet Gynecol 15 (2003), 147–157.
111. Odibo, A.O., Quinones, J.N., Lawrence-Cleary, K., et al. What antepartum fetal test should guide the timing of delivery of the preterm growth-restricted fetus? A decision-analysis. Am J Obstet Gynecol 191 (2004), 1477–1482.
112. Baschat, A.A., Harman, C.R., Venous Doppler in the assessment of fetal cardiovascular status. Curr Opin Obstet Gynecol 18 (2006), 156–163.
113. Del, R.M., Martinez, J.M., Figueras, F., et al. Doppler assessment of fetal aortic isthmus blood flow in two different sonographic planes during the second half of gestation. Ultrasound Obstet Gynecol 26 (2005), 170–174.
114. Francisco, R.P., Miyadahira, S., Zugaib, M., Predicting pH at birth in absent or reversed end-diastolic velocity in the umbilical arteries. Obstet Gynecol 107 (2006), 1042–1048.
115. Ritter, S., Jorn, H., Weiss, C., et al. Importance of ductus venosus Doppler assessment for fetal outcome in cases of intrauterine growth restriction. Fetal Diagn Ther 19 (2004), 348–355.
116. Figueras, F., Martinez, J.M., Puerto, B., et al. Contraction stress test versus ductus venosus Doppler evaluation for the prediction of adverse perinatal outcome in growth-restricted fetuses with non-reassuring non-stress test. Ultrasound Obstet Gynecol 21 (2003), 250–255.
117. Gudmundsson, S., Importance of venous flow assessment for clinical decision-making. Eur J Obstet Gynecol Reprod Biol 84 (1999), 173–178.
118. Gudmundsson, S., Tulzer, G., Huhta, J.C., et al. Venous Doppler in the fetus with absent end-diastolic flow in the umbilical artery. Ultrasound Obstet Gynecol 7 (1996), 262–267.
119. Wladimiroff, J.W., Tonge, H.M., Stewart, P.A., Doppler ultrasound assessment of cerebral blood flow in the human fetus. Br J Obstet Gynaecol 93 (1986), 471–475.
120. Oepkes, D., Brand, R., Vandenbussche, F.P., et al. The use of ultrasonography and Doppler in the prediction of fetal haemolytic anaemia: a multivariate analysis. Br J Obstet Gynaecol 101 (1994), 680–684.
121. Mari, G., Deter, R.L., Carpenter, R.L., et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 342 (2000), 9–14.
122. Kutschera, J., Tomaselli, J., Urlesberger, B., et al. Absent or reversed end-diastolic blood flow in the umbilical artery and abnormal Doppler cerebroplacental ratio—cognitive, neurological and somatic development at 3 to 6 years. Early Hum Dev 69 (2002), 47–56.
123. Detti, L., Mari, G., Akiyama, M., et al. Longitudinal assessment of the middle cerebral artery peak systolic velocity in healthy fetuses and in fetuses at risk for anemia. Am J Obstet Gynecol 187 (2002), 937–939.
124. Schild, R.L., Bald, R., Plath, H., et al. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 13 (1999), 161–166.
125. Moise, K.J. Jr, Diagnosing hemolytic disease of the fetus—time to put the needles away?. N Engl J Med 355 (2006), 192–194.